![]() |
Dr. Emily Miller explains elements of a fetal ultrasound to fellow study author Dr. Rachel Ruderman. Credit: Northwestern University |
The exclusion of pregnant patients in initial COVID-19 vaccine clinical trials left many patients and doctors wondering how the vaccine might affect pregnant patients and their unborn babies. But a new Northwestern Medicine study finds the vaccine is not associated with birth defects that are detectable on ultrasound.
“This is yet another important piece of data that helps bridge the chasm that was left when pregnant individuals were excluded from those initial vaccine trials,” said corresponding author Dr. Emily Miller, chief of obstetrics at Northwestern Medicine and assistant professor of maternal fetal medicine at Northwestern University Feinberg School of Medicine.
The study was published April 4 in the journal JAMA Pediatrics.
“One of the reasons women struggle with the vaccine in pregnancy is they’re worried about their babies and don’t want to take any risks,” said first author Dr. Rachel Ruderman, a fourth-year resident in obstetrics and gynecology at Feinberg. “This study shows there really is no increased risk of birth defects, and it supports other evidence that shows the vaccine is safe and beneficial for mom and baby.”